Adagene Inc.: Form 20-F for the period ended Dec 31, 2020
Filed with the SEC on Apr 28, 2021 and accepted by EDGAR at Apr 28, 2021, 06:09 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2020-01-01 to 2020-12-31 | $700.9k | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 12 months2020-01-01 to 2020-12-31 | $33.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2020-01-01 to 2020-12-31 | −$43.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2020-01-01 to 2020-12-31 | $202.2k | us-gaap:InterestExpense |
| Net income | 12 months2020-01-01 to 2020-12-31 | −$42.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2020-01-01 to 2020-12-31 | −$2.67 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2020-01-01 to 2020-12-31 | −$2.67 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-01-01 to 2020-12-31 | 15,950,698 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | −$28.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-01-01 to 2020-12-31 | $935.2k | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2020-12-31 | $75.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $79.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $84.3m | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $16.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $19.2m | us-gaap:Liabilities |
| Long-term debt | At period end2020-12-31 | $3.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-12-31 | $1.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2020-12-31 | −$89.4m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2020-12-31 | 43,852,894 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-21-055911. Last ingested by Listed: Nov 9, 2026, 17:22 ET. Listed shows no prices and gives no investment advice.